Wall Street Reporter's Newest Edition of the Biomed Business Journal is Now Available

New York (PRWEB) August 14, 2005 -- Wall Street Reporter has issued its newest edition of the Biomed Business Journal. This full-color, quarterly, print magazine features interviews, articles and analyst roundtable discussions with the leading executive and industry analysts in the biotechnology, medical device and healthcare industries that are making an impact today on the future of medicine and tomorrow's standard of care.

Featured CEO Interviews:
Memry Corporation (AMEX: MRY)
Aeterna Zentaris (NASDAQ: AEZS; TSX: AEZ)
American Medical Systems Holdings(NASDAQ: AMMD)
Inion Ltd. (LSE: IIN)
CyBio AG (FSE: CQJ)
Acrux Limited (ASX: ACR)
Advanced Nanotechnology Limited (ASX: ANO)
Bespak Plc (LSE: BPK)
MedicalCV, Inc. (OTCBB: MDCV)
Agendia BV (PRIVATE)
XDx, Inc., (PRIVATE)
Xanodyne Pharmaceuticals, Inc. (PRIVATE)
REPLIcor, Inc. (PRIVATE)
Predix Pharmaceuticals, Inc. (PRIVATE)
Absorption Systems, Inc. (PRIVATE)
Alphavax, Inc. (PRIVATE)
ActivX, Inc. (PRIVATE)
Targeted Molecular Diagnostics, LLC (PRIVATE)

Featured Analyst/CEO Roundtable Conference Call:
The Long-Term Potential of Stem Cells
William Kridel Jr. (moderator)
Managing Director
Ferghana Partners

R. Douglas Armstrong, Ph.D.
Chairman and Chief Executive Officer
Aastrom Biosciences, Inc.

Daniel Marshak, Ph.D.
Vice President and CTO(Biotechnology)
Cambrex Corp.

Howard J. Leonhardt
Chairman and Chief Executive Officer
Bioheart Inc.

Featured CEO Viewpoints:

Trends in Disease Management
Trends in Cardiology

To get your copy of this recent edition contact:
Nadejada Bojinova
Research Analyst
212-363-2600 ext.234

About the Wall Street Reporter
The Wall Street Reporter is a premier information source for professional investors seeking accurate and up-to-date investment information on companies making news. Today, the Wall Street Reporter reaches every area of the financial community. Our library has grown to over 22,000 interviews and our business now extends from five print and online magazines to investor events, roundtables, radio, and television. More than 80,000 portfolio managers, analysts, venture capitalists, and other decision makers (not to mention 3,500 financial editors, reporters, and TV producers) read our publications.

http://www.wallstreetreporter.com

###